News

Find News

Filter articles

Showing 21 to 30 of 2383 results

University of California to be granted CRISPR patent

US11-02-2019

The University of California will soon be granted a patent related to the gene-editing technology CRISPR, according to a notice of allowance by the US Patent and Trademark Office.

Fed Circuit dismisses Momenta appeal in BMS suit

US08-02-2019

The US Court of Appeals for the Federal Circuit yesterday dismissed an appeal by Massachusetts-based biotech Momenta Pharmaceuticals in a case involving a rheumatoid arthritis drug.

Victory for Mayo in neurological disorder patent dispute

US07-02-2019

In a victory for Mayo Collaborative Services, a US Court has ruled that four claims in a patent, of which Athena Diagnostics is the exclusive licensee, are invalid.

EU court rules on Swedish medical devices TM dispute

EU, Sweden07-02-2019

The EU General Court today upheld the decision to invalidate a trademark owned by Swemac Innovation, a Swedish medical devices company.

Jury orders Takeda subsidiary to pay Bayer $155 million

US06-02-2019

A US jury has ordered pharmaceutical company Baxalta Inc. to pay $155 million to Bayer Healthcare following a patent infringement trial.

GSK and Merck KGaA unite in €3.7bn immunotherapy deal

Germany, UK06-02-2019

UK headquartered GSK has made another move in the oncology space, signing a potential €3.7 billion immunotherapy deal with Germany-based Merck KGaA.

Fed Circuit refusal paves way for Suboxone generics

US05-02-2019

Rivals of British pharmaceutical company Indivior will soon be able to sell generic versions of opioid addiction treatment Suboxone film following a ruling of the US Court of Appeals for the Federal Circuit.

Philippines targets manufacturers of counterfeit rabies vaccines

Asia04-02-2019

The Philippines Food and Drug Administration has issued a closure notice for a company allegedly responsible for producing counterfeit rabies vaccines.

Fed Circuit rules against Mylan in patent dispute over epilepsy drug

US04-02-2019

Generic-drug manufacturers Mylan Pharmaceuticals, Breckenridge Pharmaceutical and Alembin Pharmaceuticals have lost their bid to prove that claims in a patent owned by US company Research Corporation Technologies, were invalid on the grounds of obviousness.

Chinese AI start-up opens R&D centre in Singapore

Singapore01-02-2019

Chinese artificial intelligence start-up Yitu Technology has launched a new research and development centre in Singapore which will focus partly on applying the technology to medical diagnostics.

Showing 21 to 30 of 2383 results

LSIPR